| Patent | Date |
|---|
Radioimmunoconjugate For Use In Treating Bone Marrow Associated Diseases
App 20190388571 - ORCHARD; Kim ; et al. | 2019-12-26 |
Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies
Grant 9,072,797 - Benes , et al. July 7, 2 | 2015-07-07 |
Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
Grant 8,552,159 - Bosslet , et al. October 8, 2 | 2013-10-08 |
Recombinant Newcastle Disease Virus
App 20110020282 - BEIER; Rudolf ; et al. | 2011-01-27 |
Immunoconjugate For Human Cd66 For The Treatment Of Multiple Myeloma And Other Haematological Malignancies
App 20100183505 - Benes; Ivan ; et al. | 2010-07-22 |
Chimeric antibody against tumor associated antigens and its use in diagnosing tumors
Grant 7,662,383 - Bosslet , et al. February 16, 2 | 2010-02-16 |
Effector conjugates, methods for their preparation and their pharmaceutical use
Grant 7,605,136 - Bosslet , et al. October 20, 2 | 2009-10-20 |
Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
App 20090246132 - Bosslet; Klaus ; et al. | 2009-10-01 |
High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity
App 20090081207 - MENRAD; ANDREAS ; et al. | 2009-03-26 |
Recombinant Newcastle Disease Virus
App 20080206201 - Beier; Rudolf ; et al. | 2008-08-28 |
New effector conjugates, process for their production and their pharmaceutical use
App 20080166362 - Berger; Markus ; et al. | 2008-07-10 |
Effector conjugates, process for their production and their pharmaceutical use
Grant 7,335,775 - Berger , et al. February 26, 2 | 2008-02-26 |
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
Grant 7,314,753 - Opper , et al. January 1, 2 | 2008-01-01 |
Fusion proteins for prodrug activation
Grant 7,273,727 - Gehrmann , et al. September 25, 2 | 2007-09-25 |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
Grant 7,241,595 - Kolar , et al. July 10, 2 | 2007-07-10 |
New effector conjugates, process for their production and their pharmaceutical use
App 20070088060 - Berger; Markus ; et al. | 2007-04-19 |
Fusion proteins for prodrug activation
App 20060292139 - Gehrmann; Mathias ; et al. | 2006-12-28 |
New effector conjugates, methods for their preparation and their pharmaceutical use
App 20060276413 - Bosslet; Klaus ; et al. | 2006-12-07 |
Effector conjugates, process for their production and their pharmaceutical use
Grant 7,129,254 - Berger , et al. October 31, 2 | 2006-10-31 |
Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
App 20060159682 - Bosslet; Klaus ; et al. | 2006-07-20 |
Fusion proteins for prodrug activation
Grant 7,060,495 - Gehrmann , et al. June 13, 2 | 2006-06-13 |
New effector conjugates, process for their production and their pharmaceutical use
App 20050234247 - Klar, Ulrich ; et al. | 2005-10-20 |
Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof
Grant 6,926,896 - Bosslet , et al. August 9, 2 | 2005-08-09 |
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
App 20050100984 - Opper, Martin ; et al. | 2005-05-12 |
New effector conjugates, process for their production and their pharmaceutical use
App 20050026971 - Berger, Markus ; et al. | 2005-02-03 |
Pharmaceuticals For Treating Sepsis And Septic Shock
App 20040214756 - DICKNEITE, GERHARD ; et al. | 2004-10-28 |
Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy
App 20040202646 - Bosslet, Klaus ; et al. | 2004-10-14 |
Effector conjugates, methods for their preparation and their pharmaceutical use
App 20040167083 - Bosslet, Klaus ; et al. | 2004-08-26 |
Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof
App 20040091488 - Seeman, Gerhard ; et al. | 2004-05-13 |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
Grant 6,610,299 - Kolar , et al. August 26, 2 | 2003-08-26 |
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
Grant 6,602,688 - Opper , et al. August 5, 2 | 2003-08-05 |
Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof
Grant 6,548,067 - Seeman , et al. April 15, 2 | 2003-04-15 |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
App 20030064482 - Kolar, Cenek ; et al. | 2003-04-03 |
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
Grant 6,475,486 - Kolar , et al. November 5, 2 | 2002-11-05 |
Fusion Proteins For Prodrug Activation
App 20020068329 - GEHRMANN, MATHIAS ; et al. | 2002-06-06 |
Monoclonal Antibodies (mabs) Against Tumor-associated Antigens, The Preparation And Use Thereof
App 20020068056 - BOSSLET, KLAUS ; et al. | 2002-06-06 |
Radioimmuno conjugates for use in human therapy and method for their preparation
Grant 6,241,961 - Benes , et al. June 5, 2 | 2001-06-05 |
Prodrugs, their preparation and use as pharmaceuticals
Grant 6,146,658 - Bosslet , et al. November 14, 2 | 2000-11-14 |
Preparation having increased in vivo tolerability
Grant 6,020,315 - Bosslet , et al. February 1, 2 | 2000-02-01 |
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion proteins in E. coli
Grant 6,008,023 - Opper , et al. December 28, 1 | 1999-12-28 |
Tetravalent bispecific receptors, the preparation and use thereof
Grant 5,959,083 - Bosslet , et al. Sept | 1999-09-28 |
Prodrugs their preparation and use as pharmaceuticals
Grant 5,955,100 - Bosslet , et al. September 21, 1 | 1999-09-21 |
Prodrugs for the therapy of tumors and inflammatory disorders
Grant 5,935,995 - Bosslet , et al. August 10, 1 | 1999-08-10 |
Monoclonal antibody against complexed and non-complexed complexing agents for removing heavy metals from aqueous solutions and for analysis
Grant 5,907,034 - Bosslet , et al. May 25, 1 | 1999-05-25 |
Pro-prodrugs, their production and use
Grant 5,877,158 - Bosslet , et al. March 2, 1 | 1999-03-02 |
Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
Grant 5,830,880 - Sedlacek , et al. November 3, 1 | 1998-11-03 |
Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
Grant 5,710,134 - Bosslet , et al. January 20, 1 | 1998-01-20 |
Granulocyte-binding antibody constructs, their preparation and use
Grant 5,645,817 - Seemann , et al. July 8, 1 | 1997-07-08 |
Use of pairs of leucine zipper peptides in immunoassay methods
Grant 5,643,731 - Bosslet , et al. July 1, 1 | 1997-07-01 |
Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
Grant 5,639,622 - Bosslet , et al. June 17, 1 | 1997-06-17 |
Prodrugs for enzyme mediated activation
Grant 5,621,002 - Bosslet , et al. April 15, 1 | 1997-04-15 |
Bispecific and oligospecific mono-and oligovalent receptors, the preparation and use thereof
Grant 5,591,828 - Bosslet , et al. J | 1997-01-07 |
Glycosylated prodrugs, their method of preparation and their uses
Grant 5,561,119 - Jacquesy , et al. October 1, 1 | 1996-10-01 |
| 